Synthetic phosphoethanolamine law in Brazil
DOI:
https://doi.org/10.17566/ciads.v7i1.468Keywords:
Brazilian Health Surveillance Agency, Government Regulation, JudiciaryAbstract
Objective: The objective was to analyze the context in which the aforementioned law was proposed and approved, in light of Brazilian legislation. Methodology: This was a descriptive-analytical study, considering that a theoretical review of the information available on the House Bill PL 4.639 / 2016, Federal Senate PLC No. 3/2016 and the Law of Phosphoethanolamine, Law 13,269, of April 13, 2016, in addition to the normative review of the attributions and competencies of Brazilian Health Surveillance Agency. Results: It is clear that a whole legal framework has been replaced by ordinary legislation with concrete effects. Conclusions: In the case in question, Brazilian Health Surveillance Agency performance was disregarded, since it is up to the Agency to carry out all the tests and subsequently release the product for consumption.Downloads
Download data is not yet available.
Downloads
Additional Files
Published
2018-04-02
Issue
Section
ARTICLES
License
Authors and coauthors retain copyright but license the right of first publication to the Iberoamerican Journal of Health Law.
The Journal has been using CC Attribution 4.0 International (CC BY 4.0) since January 2023. This license allows the user to share and adapt the work, but they must give the appropriate credit to authors and coauthors and mention the Iberoamerican Journal of Health Law. The license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International was used until 2022.
How to Cite
1.
Synthetic phosphoethanolamine law in Brazil. Cad. Ibero Am. Direito Sanit. [Internet]. 2018 Apr. 2 [cited 2024 May 19];7(1):215-28. Available from: https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/468